Skip to main content

03-01-2019 | Retinopathy | Video | Article

Diabetic retinopathy: Treatment

Speakers: Philip Burgess, John Wilding

Speaker biosDisclosures

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss the treatment of sight-threatening retinopathy and maculopathy in people with diabetes (9:11).

Learning points

  • The impact of laser treatment on VEGF production in the peripheral retina.
  • Recent evidence demonstrating the efficacy of anti-VEGF monoclonal antibodies  delivered via intravitreal injection.
  • The key treatment benefits and drawbacks for choosing injection therapy versus laser therapy
  • The approaches being investigated to minimize the treatment burden and drawbacks associated with multiple anti-VEGF monoclonal antibody injections and laser treatment.
  • New approaches being investigated including, endothelial progenitor cell based therapy.

More videos in this series

Related topics

More on this topic

Image Credits